Avadel Pharmaceuticals plc’s recent filing unveils that its Director Glass Geoffrey Michael acquired Company’s shares for reported $96300.0 on Jun 01. In the deal valued at $2.14 per share,45,000 shares were bought. As a result of this transaction, Glass Geoffrey Michael now holds 45,000 shares worth roughly $ 0.26 million.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Then, Ende Eric J bought 20,000 shares, generating $45,496 in total proceeds. Upon buying the shares at $2.27, the Director now owns 134,900 shares.
Before that, Ende Eric J bought 15,000 shares. Avadel Pharmaceuticals plc shares valued at $32,394 were divested by the Director at a price of $2.16 per share. As a result of the transaction, Ende Eric J now holds 114,900 shares, worth roughly $0.68 million.
Jefferies downgraded its Avadel Pharmaceuticals plc [AVDL] rating to a Hold from a a Buy in a research note published on Friday, August 10, 2022; the price target was increased to $8 from $6. PT values the company’s stock at a premium of 26.5 to its Friday closing price. Stifel also remained covering AVDL and has decreased its forecast on May 26, 2022 with a “Hold” recommendation from previously “Buy” rating. Needham started covering the stock on September 23, 2021. It rated AVDL as “a Buy”.
Price Performance Review of AVDL
On Friday, Avadel Pharmaceuticals plc [NASDAQ:AVDL] saw its stock fall -14.41% to $5.88. On the same session, the stock had its day’s lowest price of $5.70, but rose to a high of $6.87. Over the last five days, the stock has lost -6.52%. Avadel Pharmaceuticals plc shares have fallen nearly -27.23% since the year began. Nevertheless, the stocks have fallen -43.13% over the past one year. While a 52-week high of $11.59 was reached on 10/05/22, a 52-week low of $1.05 was recorded on 05/26/22. SMA at 50 days reached $5.92, while 200 days put it at $5.47. A total of 1.19 million shares were traded, compared to the trading of 0.55 million shares in the previous session.
Levels Of Support And Resistance For AVDL Stock
The 24-hour chart illustrates a support level at 5.43, which if violated will result in even more drops to 4.98. On the upside, there is a resistance level at 6.60. A further resistance level may holdings at 7.32. The Relative Strength Index (RSI) on the 14-day chart is 47.21, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.35%. Stochastics %K at 60.94% indicates the stock is a holding.
How much short interest is there in Avadel Pharmaceuticals plc?
A steep rise in short interest was recorded in Avadel Pharmaceuticals plc stocks on Jul 14, 2022, dropping by -0.61 million shares to a total of 5.35 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 5.96 million shares. There was a decline of -11.4%, which implies that there is a negative sentiment for the stock.
Avadel Pharmaceuticals plc [AVDL] – Who Are The Largest Shareholders?
In filings from RTW Investments LP, it is revealed that the company now owns 5,741,939 shares, or roughly 9.73% of the outstanding AVDL shares. Additionally, Tontine Associates LLC increased 50.09% of its stake after which the total value it holdings stand at $21,336,067. Over the last quarter, Brandes Investment Partners LP purchased 642,800 shares of Avadel Pharmaceuticals plc, while Polar Capital LLP bought -386,662 shares. At present, Wealth Effects LLC is holding 2,584,090 shares valued at $12.95 million. Woodline Partners LP owned 1,585,292 shares of the company at the time of its most recent 13F filing, worth $7.94 million.
According to FactSet, Avadel Pharmaceuticals plc’s share price will average $11.25 in the next year, based on opinions of analysts polled by the firm. This is up nearly 74.67 percent from its previous closing price of $6.87. Analysts expect Avadel Pharmaceuticals plc stock to reach the higher price of $14.50, while the lowest price estimate is $6.00. However, 10 analysts have rated AVDL stock as a Buy in their predictions for 2022. The most recent change occurred on July 31, 2020 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $19 price target.